Search Cosmetics & Toiletries

Not finding what you're looking for? Search the CBR.

977 Results

Section: Regulations > Regional

Unregistered foreign cosmetics imported for resale require prior recordation with China's FDA and must follow the related labeling provisions.

3 Paths to Secure Enforcement Against Parallel Chinese Cosmetic Imports

Although parallel cosmetic imports do not violate Chinese trademark law, a recent report in the National Law Review outlined three approaches businesses can take to secure enforcement action against unconsented resales.

While the overall trend for color cosmetics has been positive, a return to pre-pandemic levels appears to be progressing slowly.

Lipstick Forecasts Not So Rosy, FDA Color Additives Report Reveals

Many trend agencies and news outlets are reporting an increase in lipstick sales for 2022 but those numbers may not paint the full picture. Here's what the latest FDA Color Additives report reveals, as outlined by industry expert Kelly Dobos.

Sharon McGuinness, Ph.D., executive director of ECHA

Sharon McGuinness, Ph.D., Announced as ECHA's Executive Director

McGuinness has been the CEO of the Health and Safety Authority (HSA) in Ireland since 2018.

Revisions include adding “special cosmetics” and “cosmetics using new ingredients” to the key categories of sampling testing.

China Revises Cosmetic Sampling Testing Rules, Calls for Comments

The measures will focus on testing in children’s cosmetics, special cosmetics and cosmetics containing new ingredients. Measures are open to public comment through July 14, 2022.

Olumiant is a Janus kinase (JAK) inhibitor, which blocks the activity of one or more of a specific family of enzymes, interfering with the pathway that leads to inflammation, thereby, treating patients with alopecia areata.

FDA Approves First Systemic Alopecia Areata Treatment

Olumiant is a Janus kinase (JAK) inhibitor, which blocks the activity of one or more of a specific family of enzymes, interfering with the pathway that leads to inflammation to thereby treat patients with alopecia areata.

'I’m glad we were able to work in this legislation to ensure the FDA can, at long last, provide meaningful oversight to cosmetics and dietary supplements.'

US Senate Bill to Strengthen Cosmetic Oversight Advances

Among other changes, the bill would make the FDA's Voluntary Cosmetic Registration Program mandatory.

The UK and EU have made robust regulatory changes due to recently trending ingredient concerns. Updated guidances for lilial, DHA and cyclic silicones are outlined here, along with other regional updates.

European Regulatory Update: UK and EU Ingredient Management

The UK and EU have made robust regulatory changes due to recently trending ingredient concerns. Updated guidances for lilial, DHA and cyclic silicones are outlined here, along with other regional updates.

While Estée Lauder's virtual try-on tool, powered by YouCam, offers a link to the company's privacy policy, that material reportedly does not disclose that 'the makeup company collects, captures, possesses or otherwise obtains consumers' sensitive biometric data.'

The Estée Lauder Companies' Virtual Try-on Targeted by Lawsuit

Plaintiffs allege that The Estée Lauder Companies, Inc. engaged in "undisclosed collection of consumers’ biometric facial scans in Illinois."

Reauthorization fee programs have been considered “must pass” and are often used to advance other priorities related to FDA regulation; in this case, dietary supplements and cosmetics reforms.

Senate Considers FDA Fee Reauthorization Approach to Cosmetic Oversight

Senate members will present a draft legislation to reform the U.S. Food and Drug Administration's (FDA's) oversight of cosmetics, supplements and some lab-based tests based on a fee reauthorization approach, STAT reports.

As the first quarter of 2022 came to a close, several regulatory changes were announced in the Asia-Pacific region. Following is an overview, which includes ingredient restrictions, claims guidelines, adverse reactions and more.

Asia-Pacific Regulatory Update: GMPs, Safety, Ingredient Restrictions, Claims and More

As the first quarter of 2022 came to a close, several regulatory changes were announced in the Asia-Pacific region. Following is an overview, which includes ingredient restrictions, claims guidelines, adverse reactions and more.

The FDA has received reports of serious side effects including skin rashes, facial swelling and discoloration from the use of skin brighteners containing hydroquinone.

FDA Flags 12 Companies for Illicit Hydroquinone-containing Skin Brighteners

The products contain the active drug hydroquinone, rendering them unapproved over-the-counter (OTC) drugs rather than cosmetics.

China's National Institutes for Food and Drug Control (NIFDC) plans to introduce a more systematic and comprehensive standard consistent with the current industry situation.

China Drafts 2022 Safety and Technical Standard for Cosmetics

This draft will supersede the 2015 edition, which includes the overarching technical standards for cosmetics safety supervision and testing in China. Public comments will be accepted through April 30, 2022.

Initially designated as drugs in the U.S., sunscreens have been stifled under regulations and bureaucracy. This article reviews how it came to this, where current regulations stand and proposes a few “pipe dream” solutions.

Sunscreens and Pipe Dreams for their Regulation in the US

Initially designated as drugs in the U.S., sunscreens have been stifled under regulations and bureaucracy. This article reviews how it came to this, where current regulations stand and proposes a few “pipe dream” solutions.

Health Canada has issued recalls for three personal care products since January 2022, two for microbial contamination, and the third for potential benzene.

Health Canada Recalls Bioderma Micellar Water, Brut Deo, Equate Oral Rinse

In recent months, Health Canada has recalled Bioderma Sensibio H2O Micellar Water and Equate Dry Mouth Oral Rinse due to microbial contamination. Also, Unilever's Brut Classic Aerosol Spray deodorant was recalled for potential benzene content.

The inner packaging of a serum and product kit containing said serum listed SPF when the product has no SPF.

FDA Flags Color Additive, SPF and Contaminant Offenses, Urges 'Recall Readiness'

In recent months, the U.S. Food and Drug Administration (FDA) reported six voluntary recalls for an impermissible color additive, mislabeled SPF and several contaminants. It also urged companies to be "recall ready" and provided final guidance to do so.

Olaplex No. 3 Hair Perfector is now gaining negative attention for an ingredient it no longer contains.

Consumers Alarmed Over Lilial Ban and Social Media Misdirection with Olaplex

Lilial is now classified as a carcinogenic, mutagenic or reprotoxic (CMR) Category 1B substance and is banned in the EU. In relation, Glamour recently shamed TikTok videos for misleading consumers that Olaplex No. 3 contains it and is also banned.

In parallel with the Green Deal, the EU will outline sustainability measures and crack down on packaging waste, plastics and green claims. This column provides and overview, along with a brief look at microbiome claims.

European Regulatory Update: EGD, Packaging and Green Claims

In parallel with the Green Deal, the EU will outline sustainability measures and crackdown on packaging waste, plastics and green claims. This column provides an overview, along with a brief look at microbiome claims.

The bill aims is to provide greater clarity and flexibility to hemp growers and processors.

[updated] Hemp Act Proposes Higher THC Test Limits but Could Impact CBDs

The Hemp Advancement Act of 2022 seeks to eliminate unworkable testing requirements and set reasonable THC thresholds, according to Forbes. But could it impact other cannabinoids?

Page 1 of 55